Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products.

Xu, Biao

Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. [electronic resource] - FASEB journal : official publication of the Federation of American Societies for Experimental Biology Jul 2003 - 1289-91 p. digital

Publication Type: Journal Article

1530-6860

10.1096/fj.02-0490fje doi


Animals
Antibodies--pharmacology
Aorta--drug effects
Arginine--metabolism
Blood Pressure--drug effects
Cells, Cultured
Citrulline--biosynthesis
Diabetes Mellitus--blood
Endothelium, Vascular--drug effects
Enzyme Inhibitors--pharmacology
Female
Femoral Artery--drug effects
Glycation End Products, Advanced--pharmacology
Humans
In Vitro Techniques
Lysine--analogs & derivatives
Male
Models, Biological
NG-Nitroarginine Methyl Ester--pharmacology
Nitric Oxide--biosynthesis
Nitric Oxide Synthase--antagonists & inhibitors
Nitric Oxide Synthase Type III
Rabbits
Receptor for Advanced Glycation End Products
Receptors, Immunologic--antagonists & inhibitors
Vasodilation--drug effects